he internal thoracic artery provides better long-term patency than does the saphenous vein as a conduit for coronary bypass, prompting cardiac surgeons to explore other arterial conduits. The radial artery was first used by Carpentier in 1971, 1 because of a number of potential advantages, including ease of harvesting, a low propensity for wound infection, a larger diameter than other arterial grafts, and a thick, muscular wall that facilitates the construction of an anastomosis. However, early experience suggested that radial-artery grafts were prone to spasm and functional occlusion, and their use was abandoned for many years. 2, 3 The advent of drug therapy to prevent graft spasm and the adoption of newer harvesting techniques have revitalized interest in the radial artery as an additional arterial conduit, 4 although an observational study has raised questions regarding its long-term patency. 5 To evaluate the potential role of the radial artery as a bypass conduit, we conducted a randomized trial to determine whether the patency rate of radialartery grafts at 8 to 12 months exceeds that of saphenous-vein grafts. We used a study design that controlled for bias in the selection of patients and vessels.
study design
The study design has been described in detail elsewhere. 6 In brief, each patient received both a radial-artery graft and a saphenous-vein graft, but these were randomly allocated to two different coronary territories. Although the random assignment of grafts rather than patients precludes meaningful clinical comparisons, it serves to control for bias in patient and vessel selection and permits an unbiased comparison of the two types of grafts in terms of patency, the primary determinant of survival. Thus, the primary study objective was to compare the angiographic patency of radial-artery grafts with that of saphenous-vein grafts 8 to 12 months after surgery.
patient population
Patients less than 80 years of age who were undergoing primary, isolated coronary bypass surgery on a nonemergency basis were eligible for the study if they had graftable triple-vessel disease and an estimated left ventricular ejection fraction greater than 35 percent. The target coronary vessels were the left circumflex and right coronary arteries, which had to be at least 1.5 mm in diameter, with proximal lesions causing narrowing of at least 70 percent of the diameter. Exclusion criteria included nonpalpable ulnar arteries or a positive Allen's test; an abnormal Doppler study or ultrasonographic study of the arms; or a history of vasculitis or Raynaud's syndrome, bilateral varicose veins or vein stripping, or conditions that affected the safety of follow-up angiography, as described elsewhere. 6 The study was approved by the research ethics committee at each participating center. All patients provided written informed consent.
randomization and study procedures
Randomization was carried out in the operating room with the use of sealed envelopes, with stratification according to site and a randomly determined block size of four to six. Patients were randomly assigned to undergo surgery according to one of two strategies: radial-artery grafting to the circumflex territory and saphenous-vein grafting to the right coronary artery or radial-artery grafting to the right coronary artery and saphenous-vein grafting to the circumflex territory. With randomization performed within rather than between patients, each patient served as his or her own control for patient-level factors.
The internal thoracic artery was used to bypass the distribution of the left anterior descending coronary artery. Additional grafts were constructed as necessary. Single rather than sequential grafts were constructed; full details of the surgical technique have been previously reported. 7 
Postoperative Management and Follow-up
Patients received 325 mg of aspirin within six hours postoperatively and daily thereafter. Intravenous nitroglycerin was administered for 24 hours postoperatively. Treatment with vasoconstrictor agents was avoided whenever possible. Oral calcium-channel blockade was initiated on the first postoperative day and continued for six months. Study electrocardiograms were obtained preoperatively and on days 1 and 5 postoperatively. Patients were interviewed by telephone at one month, three months, six months, and yearly thereafter. If the patient had been hospitalized between interviews, in-patient records were obtained. All patients were questioned about the function of their hands and arms with the use of a modification of the Disabilities of the Arm, Shoulder and Hand questionnaire. 8 
Follow-up Angiography
Follow-up angiography was performed 8 to 12 months after surgery. Nitroglycerin was injected into each graft before filming. At least two orthogonal views each of the radial-artery graft and the control saphenous-vein graft were obtained, with continued exposure as required to visualize distal runoff and the size of the target bed.
end points
The primary end point was the proportion of radial-artery and saphenous-vein grafts that were completely occluded at follow-up angiography. Complete occlusion was defined as the absence of visible opacification of the target coronary vessel (i.e., Thrombolysis in Myocardial Infarction [TIMI] flow grade 0). 9 Secondary angiographic end points included perfect graft patency (TIMI flow grade 3), angiographic stenosis of any degree (assessed visually), and the presence of diffuse narrowing of the graft to less than 1 mm in diameter but with a TIMI flow grade of at least 1 (the angiographic "string sign").
Follow-up angiograms were centrally reviewed by a committee of four experienced cardiologists. Each angiogram was independently adjudicated in a blinded fashion by two committee members, with a third review in the case of disagreement.
The following clinical events were recorded: death from any cause, perioperative myocardial infarction (occurring between 0 and 30 days), late myocardial infarction (occurring between 31 days and 1 year), additional cardiac surgery, and coronary angioplasty. Hand claudication and thenar paresthesia, complications potentially related to harvesting of the radial artery, were reported according to the diagnoses specified by a consultant neurologist. Because all patients received a study radialartery graft, clinical events are reported for the entire study population only.
statistical analysis
Data from case-record forms were double entered to minimize errors. The primary comparison between the proportion of radial-artery grafts and that of saphenous-vein grafts that were occluded was performed on an intention-to-treat basis with the use of McNemar's test for paired proportional data. A P value of less than 0.048 was considered to indicate statistical significance, so as to achieve an overall level of 0.05 adjusted for a single interim analysis.
We calculated that the enrollment of 464 patients would provide the study with 80 percent power to detect a relative reduction of 40 percent in the rate of graft occlusion, from an estimated 12 percent with saphenous-vein grafting to 7.2 percent with radial-artery grafting, assuming a 20 percent within-patient correlation for graft occlusion, a twotailed test, and an alpha value of 0.05. The sample size was increased to 561 patients to allow for the lack of follow-up angiography in approximately 20 percent of patients.
patients
Thirteen centers (12 in Canada and 1 in New Zealand) enrolled 561 patients between November 1996 and January 2001. Table 1 lists the baseline characteristics of the total study population and the 440 patients who underwent postoperative angiography. Patients who underwent follow-up angiography were generally representative of the entire study population, although fewer were over the age of 70 years (P=0.01). The severity of stenosis in native coronary vessels was similar in the target vessels for radial-artery grafts and saphenousvein grafts, indicating that the randomization was balanced.
operative data
Operative data are presented in Table 2 . As described elsewhere, 7 a dilute solution of verapamil and papaverine was delivered into 92.3 percent of study radial-artery grafts to prevent spasm. Proximal anastomosis was achieved to the aorta in 98.4 percent of radial-artery grafts and 99.6 percent of saphenous-vein grafts.
One or both study grafts were not placed in 17 patients owing to the presence of ungraftable coronary arteries in 4 patients, poor quality or length of the radial artery in 6 patients, poor vein quality in 2 patients, and various individual reasons in 5 patients. The protocol specified that these patients were to be excluded from the primary analysis because of protocol violations.
In 24 cases, a patient received both radial-artery and control saphenous-vein grafts but to the territory opposite that randomly allocated. The reasons for such crossovers were inadvertent error by the surgeon in the case of 19 patients and concern about the size or quality of the radial artery in 5 cases. In the analysis of the primary end point, all these patients were analyzed according to the intention to treat rather than the treatment received.
postoperative management
The majority of patients (94.1 percent) were discharged while taking a calcium-channel blocker, and this treatment was continued for three to six months in 90.0 percent of patients. Other medications at discharge included aspirin in 92.3 percent, other antithrombotic medications in 8.7 percent, lipid-lowering drugs in 66.7 percent, and betablockers in 70.6 percent of patients. At 12 months, 91.9 percent of patients were taking aspirin and 64.9 percent were taking a lipid-lowering drug.
angiography at one year Follow-up angiography was performed in 440 of 561 randomized patients (78.4 percent). Reasons for not undergoing angiography included protocol violations in 17 patients (as described above), postoperative death before follow-up began in 8 patients, a new postoperative condition precluding the performance of research angiography in 19 patients, and late withdrawal of consent in 77 patients. In 9 of the 440 patients who underwent postoperative angiography, there was a clinical indication for the procedure. Angiography was performed a mean ( ± SD) of 4.7 ± 2.4 months after surgery in these 9 patients and a mean of 10.9 ± 4.3 months after surgery among the 431 patients who underwent angiography for research purposes alone.
primary analysis
The primary end point of complete graft occlusion occurred in 13.6 percent of saphenous-vein grafts and 8.2 percent of radial-artery grafts (60 of 440 vs. 36 of 440, P=0.009 by McNemar's test) according to the intention-to-treat analysis (Table 3) . This corresponds to an absolute difference of 5.4 percent (95 percent confidence interval, 5.0 to 5.8 percent) and a reduction in the relative risk of graft occlusion of 40 percent (95 percent confidence interval, 28 to 52 percent) with radial-artery grafting, as compared with saphenous-vein grafting. When analyzed according to the treatment received, the results were nearly identical. In total, both study grafts were patent in 350 patients, both study grafts were occluded in 6 patients, only the radial-artery graft was occluded in 30 patients, and only the saphenous-vein graft was occluded in 54 patients.
The angiographic string sign was present in 7.0 percent of radial-artery grafts and 0.9 percent 
adverse events
One patient required readmission because of infection at the site at which the radial artery was harvested. One patient had a hand-questionnaire score greater than 18, implying clinically significant functional limitation. Thirty-two patients (5.7 percent) reported moderate-to-severe symptoms of thenar paresthesia or numbness at 1 month, and this number had decreased to six (1.1 percent) at the 12-month follow-up assessment. Ten patients (1.8 percent) reported moderate-to-severe weakness of the hand at 1 month, and this number had decreased to five (0.9 percent) at the 12-month follow-up assessment. No patient reported hand claudication or ischemia. There were no reports of adverse events during follow-up angiography.
clinical end points
Clinical follow-up information was available for all study patients for the first year ( Table 4 ). The one-year survival rate was 98.6 percent (553 of 561 patients). Nonfatal perioperative myocardial infarction occurred in 9.8 percent of patients (55 of 561). The infarct location was in the territory of the radial-artery graft in 3.2 percent of patients, the control saphenous-vein graft in 3.0 percent, and internal-thoracic-artery grafts in 2.8 percent and was indeterminate in 0.7 percent of patients.
No patient underwent cardiac surgery a second time. Among four patients who underwent percutaneous coronary intervention, intervention was performed on one radial-artery graft at the proximal anastomosis, on two control saphenous-vein grafts, and on one native coronary artery distal to the insertion of a control saphenous-vein graft. At one year, the overall rate of the composite end point of death from cardiac causes, nonfatal myocardial infarction, or repeated revascularization was 11.6 percent.
In this large, randomized, multicenter clinical trial, radial-artery bypass grafts had a higher rate of patency at one year than did the usual saphenousvein graft, thus establishing radial-artery grafts as a second arterial conduit for targets other than the left anterior descending coronary artery. Previous studies have established the superiority of the left internal thoracic artery over saphenous-vein grafts for revascularization of the left anterior descending coronary artery. 10 A recent observational series showed reduced patency of the radial-artery graft as compared with that of other conduits. 5 However, that study did not use standardized surgical methods and concurrent pharmacotherapy, randomized controls, or routine angiographic follow-up, leading to potential bias in ascertainment and followdiscussion * Plus-minus values are means ±SD. There were no significant differences between patients who underwent angiography and the study group as a whole. up. In contrast, our study relied on a randomized design with routine angiographic follow-up. The study design was novel in that each patient received both the study radial-artery graft and the control saphenous-vein graft, thereby avoiding inherent bias regarding patient selection. Since the target vessel was randomly assigned, the effect of targetvessel location on graft patency could be analyzed independently. Grafting to either the left circumflex or right coronary territory did not influence patency in this study.
The relationship between the severity of proximal native-vessel stenosis and arterial-graft patency has been previously reported for internal-thoracic, gastroepiploic, and radial-artery grafts in retrospective studies. [11] [12] [13] Certain characteristics of the radial artery, including the increased wall thickness and the density and organization of myocytes, may increase the propensity of this artery for spasm when there is decreased or competitive flow. 14 Accordingly, we placed the radial artery in demanding situations by stipulating that the proximal target-vessel stenosis exceed 70 percent. Despite this inclusion criterion, a decrement in performance of radial-artery grafts was still evident in the form of higher rates of both occlusion and the angiographic string sign when they were used to bypass less severely stenotic target lesions. Fortunately, investigators have shown that inducible ischemia is uncommon in myocardial territories supplied by grafts with an angiographic string sign. 15 The patency of these grafts may also improve late in follow-up, as native-vessel stenosis progresses. 16 There were rare complications of harvesting of radial arteries in our study. A previous, larger study involving the harvesting of nearly 4000 radial arteries for coronary bypass grafting reported similarly low rates of complications of the hand and arm. 17 The incidence of occlusion in the control saphenous-vein graft at one year was 13.6 percent, consistent with previous studies of the patency of saphenous-vein grafts showing one-year occlusion rates between 10 and 15 percent. [18] [19] [20] Follow-up of patients with vein grafts has revealed a substantial incidence of atherosclerotic changes in the graft body, leading to hemodynamically significant stenoses at 10 years, with angiographic evidence of patency in only 50 to 60 percent of grafts 21 -a rate that is sharply lower than late patency rates of more than 95 percent for the left internal thoracic artery. 22, 23 The increased incidence of angiographic stenoses in vein-graft bodies, as compared with radial-artery-graft bodies in our study, suggests that even during a one-year follow-up period, atherosclerotic changes are more apparent in vein grafts. Given the natural history of accelerated atherosclerosis in vein grafts, we speculate that the su- 
